Neurobiologic processes in drug reward and addiction

Research output: Contribution to journalArticle

238 Citations (Scopus)

Abstract

Neurophysiologic processes underlie the uncontrolled, compulsive behaviors defining the addicted state. These "hard-wired" changes in the brain are considered critical for the transition from casual to addictive drug use. This review of preclinical and clinical (primarily neuroimaging) studies will describe how the delineation between pleasure, reward, and addiction has evolved as our understanding of the biologic mechanisms underlying these processes has progressed. Although the mesolimbic dopaminergic efflux associated with drug reward was previously considered the biologic equivalent of pleasure, dopaminergic activation occurs in the presence of unexpected and novel stimuli (either pleasurable or aversive) and appears to determine the motivational state of wanting or expectation. The persistent release of dopamine during chronic drug use progressively recruits limbic brain regions and the prefrontal cortex, embedding drug cues into the amygdala (through glutaminergic mechanisms) and involving the amygdala, anterior cingulate, orbitofrontal cortex, and dorsolateral prefrontal cortex in the obsessive craving for drugs. The abstinent, addicted brain is subsequently primed to return to drug use when triggered by a single use of drug, contextual drug cues, craving, or stress, with each process defined by a relatively distinct brain region or neural pathway. The compulsive drive toward drug use is complemented by deficits in impulse control and decision making, which are also mediated by the orbitofrontal cortex and anterior cingulate. Within this framework, future targets for pharmacologic treatment are suggested.

Original languageEnglish (US)
Pages (from-to)305-320
Number of pages16
JournalHarvard Review of Psychiatry
Volume12
Issue number6
DOIs
StatePublished - Nov 2004

Fingerprint

Reward
Substance-Related Disorders
Pharmaceutical Preparations
Prefrontal Cortex
Pleasure
Gyrus Cinguli
Brain
Amygdala
Cues
Compulsive Behavior
Neural Pathways
Neuroimaging
Dopamine
Decision Making

Keywords

  • Amygdala
  • Cocaine
  • Cues
  • Dopamine
  • Impulsive behavior
  • Nucleus accumbens
  • Substance-related disorders
  • Ventral tegmental area

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Neurobiologic processes in drug reward and addiction. / Adinoff, Bryon.

In: Harvard Review of Psychiatry, Vol. 12, No. 6, 11.2004, p. 305-320.

Research output: Contribution to journalArticle

@article{c48f972693b04f1ebc6dcc8b21597d0e,
title = "Neurobiologic processes in drug reward and addiction",
abstract = "Neurophysiologic processes underlie the uncontrolled, compulsive behaviors defining the addicted state. These {"}hard-wired{"} changes in the brain are considered critical for the transition from casual to addictive drug use. This review of preclinical and clinical (primarily neuroimaging) studies will describe how the delineation between pleasure, reward, and addiction has evolved as our understanding of the biologic mechanisms underlying these processes has progressed. Although the mesolimbic dopaminergic efflux associated with drug reward was previously considered the biologic equivalent of pleasure, dopaminergic activation occurs in the presence of unexpected and novel stimuli (either pleasurable or aversive) and appears to determine the motivational state of wanting or expectation. The persistent release of dopamine during chronic drug use progressively recruits limbic brain regions and the prefrontal cortex, embedding drug cues into the amygdala (through glutaminergic mechanisms) and involving the amygdala, anterior cingulate, orbitofrontal cortex, and dorsolateral prefrontal cortex in the obsessive craving for drugs. The abstinent, addicted brain is subsequently primed to return to drug use when triggered by a single use of drug, contextual drug cues, craving, or stress, with each process defined by a relatively distinct brain region or neural pathway. The compulsive drive toward drug use is complemented by deficits in impulse control and decision making, which are also mediated by the orbitofrontal cortex and anterior cingulate. Within this framework, future targets for pharmacologic treatment are suggested.",
keywords = "Amygdala, Cocaine, Cues, Dopamine, Impulsive behavior, Nucleus accumbens, Substance-related disorders, Ventral tegmental area",
author = "Bryon Adinoff",
year = "2004",
month = "11",
doi = "10.1080/10673220490910844",
language = "English (US)",
volume = "12",
pages = "305--320",
journal = "Harvard Review of Psychiatry",
issn = "1067-3229",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Neurobiologic processes in drug reward and addiction

AU - Adinoff, Bryon

PY - 2004/11

Y1 - 2004/11

N2 - Neurophysiologic processes underlie the uncontrolled, compulsive behaviors defining the addicted state. These "hard-wired" changes in the brain are considered critical for the transition from casual to addictive drug use. This review of preclinical and clinical (primarily neuroimaging) studies will describe how the delineation between pleasure, reward, and addiction has evolved as our understanding of the biologic mechanisms underlying these processes has progressed. Although the mesolimbic dopaminergic efflux associated with drug reward was previously considered the biologic equivalent of pleasure, dopaminergic activation occurs in the presence of unexpected and novel stimuli (either pleasurable or aversive) and appears to determine the motivational state of wanting or expectation. The persistent release of dopamine during chronic drug use progressively recruits limbic brain regions and the prefrontal cortex, embedding drug cues into the amygdala (through glutaminergic mechanisms) and involving the amygdala, anterior cingulate, orbitofrontal cortex, and dorsolateral prefrontal cortex in the obsessive craving for drugs. The abstinent, addicted brain is subsequently primed to return to drug use when triggered by a single use of drug, contextual drug cues, craving, or stress, with each process defined by a relatively distinct brain region or neural pathway. The compulsive drive toward drug use is complemented by deficits in impulse control and decision making, which are also mediated by the orbitofrontal cortex and anterior cingulate. Within this framework, future targets for pharmacologic treatment are suggested.

AB - Neurophysiologic processes underlie the uncontrolled, compulsive behaviors defining the addicted state. These "hard-wired" changes in the brain are considered critical for the transition from casual to addictive drug use. This review of preclinical and clinical (primarily neuroimaging) studies will describe how the delineation between pleasure, reward, and addiction has evolved as our understanding of the biologic mechanisms underlying these processes has progressed. Although the mesolimbic dopaminergic efflux associated with drug reward was previously considered the biologic equivalent of pleasure, dopaminergic activation occurs in the presence of unexpected and novel stimuli (either pleasurable or aversive) and appears to determine the motivational state of wanting or expectation. The persistent release of dopamine during chronic drug use progressively recruits limbic brain regions and the prefrontal cortex, embedding drug cues into the amygdala (through glutaminergic mechanisms) and involving the amygdala, anterior cingulate, orbitofrontal cortex, and dorsolateral prefrontal cortex in the obsessive craving for drugs. The abstinent, addicted brain is subsequently primed to return to drug use when triggered by a single use of drug, contextual drug cues, craving, or stress, with each process defined by a relatively distinct brain region or neural pathway. The compulsive drive toward drug use is complemented by deficits in impulse control and decision making, which are also mediated by the orbitofrontal cortex and anterior cingulate. Within this framework, future targets for pharmacologic treatment are suggested.

KW - Amygdala

KW - Cocaine

KW - Cues

KW - Dopamine

KW - Impulsive behavior

KW - Nucleus accumbens

KW - Substance-related disorders

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=12444281751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444281751&partnerID=8YFLogxK

U2 - 10.1080/10673220490910844

DO - 10.1080/10673220490910844

M3 - Article

VL - 12

SP - 305

EP - 320

JO - Harvard Review of Psychiatry

JF - Harvard Review of Psychiatry

SN - 1067-3229

IS - 6

ER -